Innospec (IOSP) Financials

$87.47 0.00 (0.00%)

As of 04:00 PM Eastern

Annual Income Statements for Innospec

This table shows Innospec's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	120	81	62	85	112	29	93	133	139	36
Consolidated Net Income / (Loss)	120	81	62	85	112	29	93	133	139	36
Net Income / (Loss) Continuing Operations	120	81	62	85	112	29	93	133	139	36
Total Pre-Tax Income	152	103	128	132	150	40	134	185	174	41
Total Operating Income	156	98	125	134	150	34	132	187	162	178
Total Gross Profit	346	332	403	435	466	343	435	587	591	543
Total Revenue	1,012	883	1,307	1,477	1,513	1,193	1,483	1,964	1,949	1,845
Operating Revenue	1,012	883	1,307	1,477	1,513	1,193	1,483	1,964	1,949	1,845
Total Cost of Revenue	666	551	904	1,042	1,047	850	1,049	1,377	1,358	1,303
Operating Cost of Revenue	666	551	904	1,042	1,047	850	1,049	1,377	1,358	1,303
Total Operating Expenses	190	234	278	302	316	309	303	399	430	365
Selling, General & Admin Expense	207	217	244	261	281	237	267	361	388	314
Research & Development Expense	25	25	31	33	35	31	37	39	42	48
Impairment Charge	-	-	-	0.00	0.00	20	0.00	0.00	0.00	0.00
Other Special Charges / (Income)	-41	-9.40	-	-	-	0.00	-1.80	0.00	0.00	3.20
Total Other Income / (Expense), net	-4.00	4.90	3.10	-1.90	0.50	6.00	2.30	-2.70	13	-137
Interest & Investment Income	-4.00	-3.20	-8.20	-6.90	-4.80	-1.80	-1.50	-1.10	2.30	9.30
Other Income / (Expense), net	0.00	8.10	11	5.00	5.30	7.80	3.80	-1.60	11	-146
Income Tax Expense	33	22	66	47	38	11	41	52	35	5.60
Basic Earnings per Share	$4.96	$3.39	$2.56	$3.48	$4.58	$1.17	$3.78	$5.37	$5.60	$1.43
Weighted Average Basic Shares Outstanding	24.11M	24.00M	24.15M	24.40M	24.48M	24.56M	24.65M	24.79M	24.85M	24.93M
Diluted Earnings per Share	$4.86	$3.33	$2.52	$3.45	$4.54	$1.16	$3.75	$5.32	$5.56	$1.42
Weighted Average Diluted Shares Outstanding	24.61M	24.44M	24.49M	24.60M	24.73M	24.78M	24.85M	24.98M	25.02M	25.12M
Weighted Average Basic & Diluted Shares Outstanding	24.10M	24M	24.10M	24.40M	24.51M	24.60M	24.77M	24.77M	24.87M	24.96M
Cash Dividends to Common per Share	$0.61	$0.67	$0.77	$0.89	$1.02	$1.04	$1.16	$1.28	$1.41	$1.55

This table shows Innospec's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	39	26	33	29	39	38	41	31	33	-70
Consolidated Net Income / (Loss)	39	26	33	29	39	38	41	31	33	-70
Net Income / (Loss) Continuing Operations	39	26	33	29	39	38	41	31	33	-70
Total Pre-Tax Income	49	45	45	37	48	45	55	44	45	-103
Total Operating Income	50	47	41	34	42	45	51	41	46	41
Total Gross Profit	156	152	148	150	137	156	156	127	124	136
Total Revenue	513	511	510	480	464	495	500	435	443	467
Operating Revenue	513	511	510	480	464	495	500	435	443	467
Total Cost of Revenue	357	359	362	330	327	339	345	308	319	331
Operating Cost of Revenue	357	359	362	330	327	339	345	308	319	331
Total Operating Expenses	106	105	107	116	95	111	105	86	79	95
Selling, General & Admin Expense	96	97	96	106	84	102	93	73	67	81
Research & Development Expense	10	8.40	11	11	12	8.90	12	12	11	13
Other Special Charges / (Income)	-	-	0.00	0.00	0.00	-	0.70	0.60	0.60	1.30
Total Other Income / (Expense), net	-1.20	-1.40	4.00	2.40	5.60	0.80	4.80	3.00	-0.80	-144
Interest & Investment Income	-0.30	-	0.30	-0.30	0.80	1.50	2.10	2.10	2.70	2.40
Other Income / (Expense), net	-0.90	-1.40	3.70	2.70	4.80	-0.70	2.70	0.90	-3.50	-146
Income Tax Expense	10	20	12	7.70	8.30	7.50	14	13	11	-32
Basic Earnings per Share	$1.56	$1.04	$1.34	$1.16	$1.58	$1.52	$1.66	$1.25	$1.34	($2.82)
Weighted Average Basic Shares Outstanding	24.79M	24.79M	24.80M	24.87M	24.87M	24.85M	24.89M	24.94M	24.94M	24.93M
Diluted Earnings per Share	$1.55	$1.02	$1.33	$1.16	$1.57	$1.50	$1.65	$1.24	$1.33	($2.80)
Weighted Average Diluted Shares Outstanding	24.97M	24.98M	24.96M	24.98M	25.01M	25.02M	25.07M	25.10M	25.10M	25.12M
Weighted Average Basic & Diluted Shares Outstanding	24.76M	24.77M	24.87M	24.87M	24.87M	24.87M	24.93M	24.94M	24.94M	24.96M

This table details how cash moves in and out of Innospec's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	95	-35	-12	33	-47	30	37	5.30	57	86
Net Cash From Operating Activities	118	106	83	105	162	146	93	82	207	185
Net Cash From Continuing Operating Activities	118	106	83	105	162	146	93	82	207	185
Net Income / (Loss) Continuing Operations	120	81	62	85	112	29	93	133	139	36
Consolidated Net Income / (Loss)	120	81	62	85	112	29	93	133	139	36
Depreciation Expense	35	38	50	50	48	46	43	40	39	44
Non-Cash Adjustments To Reconcile Net Income	2.60	-1.50	3.20	0.60	0.50	24	-0.90	4.20	4.70	160
Changes in Operating Assets and Liabilities, net	-39	-12	-33	-30	1.30	48	-42	-96	24	-55
Net Cash From Investing Activities	15	-209	-30	-36	-31	-30	-36	-42	-112	-62
Net Cash From Continuing Investing Activities	15	-209	-30	-36	-31	-30	-36	-42	-112	-62
Purchase of Property, Plant & Equipment	-26	-17	-28	-30	-31	-30	-39	-42	-77	-62
Acquisitions	0.00	-197	-4.20	-5.40	-	-	0.00	0.00	-35	-0.20
Sale of Property, Plant & Equipment	-	-	-	-	0.00	0.00	2.90	0.20	0.10	0.50
Net Cash From Financing Activities	-37	70	-66	-36	-178	-87	-20	-34	-39	-35
Net Cash From Continuing Financing Activities	-37	70	-66	-36	-178	-87	-20	-34	-39	-35
Repayment of Debt	-14	-22	-53	-24	-175	-76	-0.60	-0.10	-3.70	-0.30
Repurchase of Common Equity	-15	-8.40	-1.10	-1.40	-2.40	-2.10	-0.80	-5.90	-1.10	-0.70
Payment of Dividends	-15	-60	-19	-22	-25	-26	-29	-32	-35	-39
Issuance of Common Equity	1.30	2.10	6.80	1.10	1.20	2.30	10	4.00	0.90	4.50
Effect of Exchange Rate Changes	-1.10	-0.90	1.60	-0.30	-	0.20	-0.50	-0.60	0.10	-1.70

This table details how cash moves in and out of Innospec's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	29	47	0.40	18	41	-3.50	66	-30	64	-15
Net Cash From Operating Activities	40	78	22	55	58	72	81	4.70	74	26
Net Cash From Continuing Operating Activities	40	78	22	55	58	72	81	4.80	73	26
Net Income / (Loss) Continuing Operations	39	26	33	29	39	38	41	31	33	-70
Consolidated Net Income / (Loss)	39	26	33	29	39	38	41	31	33	-70
Depreciation Expense	10	9.20	9.30	9.90	9.90	10	10	11	11	11
Non-Cash Adjustments To Reconcile Net Income	0.90	1.40	1.10	1.10	1.20	1.30	1.20	1.40	1.10	157
Changes in Operating Assets and Liabilities, net	-9.90	42	-22	15	7.80	23	28	-39	28	-71
Net Cash From Investing Activities	-9.60	-15	-22	-17	-17	-56	-14	-15	-12	-21
Net Cash From Continuing Investing Activities	-9.60	-15	-22	-17	-17	-56	-14	-15	-12	-21
Purchase of Property, Plant & Equipment	-9.70	-15	-22	-17	-17	-21	-14	-15	-12	-21
Sale of Property, Plant & Equipment	-	0.10	0.00	-	-	0.10	0.10	0.10	0.10	0.20
Net Cash From Financing Activities	-0.40	-17	0.40	-19	0.20	-20	0.50	-19	0.90	-18
Net Cash From Continuing Financing Activities	-0.40	-17	0.40	-19	0.20	-20	0.50	-19	0.90	-18
Payment of Dividends	-	-16	-	-	-	-18	-	-	-	-20
Issuance of Common Equity	1.90	-	0.70	0.20	0.10	-0.10	0.90	0.70	0.90	2.00
Effect of Exchange Rate Changes	-0.70	0.30	0.20	-0.10	-0.30	0.30	-0.40	-0.30	0.90	-1.90

This table presents Innospec's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	1,029	1,181	1,410	1,473	1,469	1,397	1,571	1,604	1,707	1,735
Total Current Assets	459	441	0.00	664	630	566	728	873	886	957
Cash & Equivalents	137	102	-	123	76	105	142	147	204	289
Accounts Receivable	137	154	-	280	292	221	285	335	360	342
Inventories, net	160	174	-	248	245	220	278	373	300	301
Prepaid Expenses	6.10	6.20	-	12	15	15	18	14	19	21
Current Deferred & Refundable Income Taxes	12	4.80	-	1.50	2.50	4.20	5.80	3.30	2.80	3.10
Other Current Assets	1.80	0.00	-	0.00	0.80	0.40	0.40	0.40	0.60	0.60
Plant, Property, & Equipment, net	76	157	0.00	196	199	211	214	221	268	270
Total Noncurrent Assets	494	583	362	613	640	620	628	510	553	508
Goodwill	267	375	362	365	363	371	364	359	399	383
Intangible Assets	169	144	-	136	114	75	58	45	57	65
Noncurrent Deferred & Refundable Income Taxes	1.40	15	-	8.80	9.10	7.60	6.40	5.90	10	9.40
Employee Benefit Assets	56	48	-	96	116	118	160	48	35	2.40
Other Noncurrent Operating Assets	0.90	0.80	-	7.20	38	48	40	52	51	49
Total Liabilities & Shareholders' Equity	1,029	1,181	843	1,473	1,469	1,397	1,571	1,604	1,707	1,735
Total Liabilities	423	528	49	648	550	453	538	563	558	519
Total Current Liabilities	206	183	5.20	297	304	252	337	406	372	371
Accounts Payable	52	60	-	127	122	99	149	165	164	164
Accrued Expenses	84	95	-	132	154	130	167	203	186	169
Current Deferred & Payable Income Tax Liabilities	7.90	9.40	-	8.60	10	5.50	3.70	18	3.80	20
Other Current Liabilities	6.40	6.70	5.20	5.90	16	18	18	19	18	19
Total Noncurrent Liabilities	217	345	43	351	246	200	201	158	186	147
Asset Retirement Reserve & Litigation Obligation	31	33	41	44	44	52	51	52	57	55
Noncurrent Deferred Revenue	0.60	0.50	-	40	36	32	31	21	12	0.00
Noncurrent Deferred & Payable Income Tax Liabilities	42	35	2.50	62	66	63	77	40	47	24
Noncurrent Employee Benefit Liabilities	9.20	14	-	16	18	21	18	12	13	13
Other Noncurrent Operating Liabilities	0.50	1.00	-	2.10	24	3.50	25	33	57	55
Total Equity & Noncontrolling Interests	605	654	794	826	919	945	1,033	1,040	1,150	1,216
Total Preferred & Common Equity	605	654	794	825	919	944	1,032	1,038	1,147	1,211
Total Common Equity	605	654	794	825	919	944	1,032	1,038	1,147	1,211
Common Stock	311	315	794	325	331	336	347	354	361	370
Retained Earnings	496	562	-	668	756	759	823	924	1,028	1,025
Treasury Stock	-92	-98	-	-93	-93	-93	-91	-95	-94	-93
Accumulated Other Comprehensive Income / (Loss)	-111	-126	-	-76	-74	-57	-47	-145	-148	-91
Noncontrolling Interest	0.30	0.30	-	0.50	0.40	0.50	0.60	2.40	2.50	4.90

This table presents Innospec's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	1,669	1,624	1,611	1,619	1,733	1,700	1,798
Total Current Assets	846	875	855	864	913	877	966
Cash & Equivalents	101	148	166	207	270	240	304
Accounts Receivable	343	342	311	305	318	300	328
Inventories, net	382	366	357	332	304	314	319
Prepaid Expenses	7.40	15	11	7.70	15	9.70	9.20
Current Deferred & Refundable Income Taxes	14	3.60	9.80	11	4.40	12	5.10
Other Current Assets	0.40	0.40	0.70	1.40	0.90	1.00	0.60
Plant, Property, & Equipment, net	207	234	242	245	269	272	278
Total Noncurrent Assets	616	516	514	510	551	552	554
Goodwill	352	360	361	358	398	388	392
Intangible Assets	44	47	47	48	58	61	64
Noncurrent Deferred & Refundable Income Taxes	5.70	5.90	5.90	5.90	10	10	11
Employee Benefit Assets	163	49	49	50	36	37	38
Other Noncurrent Operating Assets	53	54	52	49	50	55	49
Total Liabilities & Shareholders' Equity	1,669	1,624	1,611	1,619	1,733	1,700	1,798
Total Liabilities	577	544	516	491	547	504	550
Total Current Liabilities	381	382	365	344	365	333	373
Accounts Payable	174	178	158	146	166	148	169
Accrued Expenses	174	164	175	165	164	143	170
Current Deferred & Payable Income Tax Liabilities	15	20	14	15	17	23	16
Other Current Liabilities	19	20	19	18	18	20	19
Total Noncurrent Liabilities	196	162	151	146	182	172	177
Asset Retirement Reserve & Litigation Obligation	50	52	53	51	57	57	59
Noncurrent Deferred Revenue	21	21	12	12	12	0.00	0.00
Noncurrent Deferred & Payable Income Tax Liabilities	76	41	41	41	45	46	47
Noncurrent Employee Benefit Liabilities	16	13	12	12	13	13	13
Other Noncurrent Operating Liabilities	34	35	33	31	56	56	58
Total Equity & Noncontrolling Interests	1,092	1,081	1,095	1,128	1,186	1,196	1,248
Total Preferred & Common Equity	1,089	1,078	1,092	1,125	1,184	1,193	1,243
Total Common Equity	1,089	1,078	1,092	1,125	1,184	1,193	1,243
Common Stock	353	355	357	359	363	365	367
Retained Earnings	915	957	969	1,008	1,070	1,082	1,115
Treasury Stock	-95	-94	-94	-94	-93	-93	-93
Accumulated Other Comprehensive Income / (Loss)	-83	-141	-140	-148	-155	-161	-145
Noncontrolling Interest	2.50	2.40	2.60	2.70	2.60	3.30	4.20

This table displays calculated financial ratios and metrics derived from Innospec's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	5.35%	-12.73%	47.93%	13.02%	2.46%	-21.16%	24.33%	32.38%	-0.76%	-5.31%
EBITDA Growth	33.54%	-24.60%	29.29%	0.75%	7.82%	-56.85%	104.11%	26.43%	-6.38%	-64.33%
EBIT Growth	36.75%	-31.99%	28.22%	1.61%	12.06%	-73.26%	227.47%	36.64%	-7.32%	-81.46%
NOPAT Growth	43.75%	-36.86%	-22.12%	42.99%	29.69%	-78.21%	275.61%	47.47%	-4.49%	19.26%
Net Income Growth	42.09%	-31.97%	-23.99%	37.54%	32.00%	-74.42%	224.39%	42.86%	4.59%	-74.41%
EPS Growth	43.79%	-31.48%	-24.32%	36.90%	31.59%	-74.45%	223.28%	41.87%	4.51%	-74.46%
Operating Cash Flow Growth	11.19%	-10.74%	-21.61%	26.84%	54.05%	-9.72%	-36.12%	-12.34%	153.73%	-11.00%
Free Cash Flow Firm Growth	-24,714.42%	67.78%	703.29%	-189.79%	123.71%	-51.44%	16.30%	93.07%	-42.57%	126.40%
Invested Capital Growth	176.89%	26.39%	-62.05%	191.60%	-1.09%	-3.85%	2.61%	0.24%	5.89%	-2.01%
Revenue Q/Q Growth	-4.23%	-0.92%	9.74%	2.87%	-0.28%	-3.81%	4.93%	5.22%	-0.81%	-1.49%
EBITDA Q/Q Growth	-2.94%	-4.12%	9.18%	0.00%	0.00%	-1.80%	-4.70%	4.39%	-0.19%	-66.26%
EBIT Q/Q Growth	-4.46%	-5.60%	9.74%	1.09%	0.26%	-2.35%	-6.79%	6.97%	-0.81%	-82.35%
NOPAT Q/Q Growth	1.86%	-13.11%	-29.60%	46.45%	10.25%	1.35%	-6.27%	0.31%	8.23%	11.50%
Net Income Q/Q Growth	3.11%	-10.36%	-30.33%	42.14%	10.54%	4.36%	-8.28%	1.22%	9.70%	-75.24%
EPS Q/Q Growth	3.85%	-10.24%	-30.39%	41.39%	10.46%	7.41%	-8.76%	0.95%	9.45%	-75.17%
Operating Cash Flow Q/Q Growth	-14.29%	-7.94%	54.00%	27.00%	-6.59%	-0.14%	12.83%	13.31%	-2.81%	-20.20%
Free Cash Flow Firm Q/Q Growth	-811.55%	-215.65%	390.16%	-58,588.86%	-29.63%	-14.18%	28.06%	182.47%	-59.76%	50.23%
Invested Capital Q/Q Growth	3.87%	29.81%	-65.90%	-6.48%	-0.18%	0.99%	-1.41%	-9.90%	2.71%	-1.79%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	34.18%	37.62%	30.86%	29.45%	30.81%	28.72%	29.32%	29.88%	30.33%	29.42%
EBITDA Margin	18.92%	16.35%	14.29%	12.74%	13.40%	7.33%	12.04%	11.50%	10.85%	4.09%
Operating Margin	15.44%	11.12%	9.57%	9.04%	9.91%	2.82%	8.91%	9.54%	8.29%	9.64%
EBIT Margin	15.44%	12.03%	10.43%	9.38%	10.26%	3.48%	9.16%	9.46%	8.83%	1.73%
Profit (Net Income) Margin	11.80%	9.20%	4.73%	5.76%	7.41%	2.41%	6.28%	6.77%	7.14%	1.93%
Tax Burden Percent	78.46%	78.86%	48.24%	64.59%	74.60%	72.29%	69.27%	72.05%	79.76%	86.41%
Interest Burden Percent	97.44%	96.99%	93.98%	95.02%	96.91%	95.66%	98.90%	99.41%	101.34%	129.15%
Effective Tax Rate	21.54%	21.14%	51.76%	35.41%	25.40%	27.71%	30.73%	27.95%	20.24%	13.59%
Return on Invested Capital (ROIC)	27.60%	10.48%	10.59%	14.06%	12.31%	2.75%	10.40%	15.12%	14.02%	16.42%
ROIC Less NNEP Spread (ROIC-NNEP)	30.30%	14.01%	9.63%	14.68%	13.34%	-6.68%	8.94%	16.47%	8.20%	64.34%
Return on Net Nonoperating Assets (RNNOA)	-6.28%	2.44%	-2.06%	-3.57%	0.55%	0.33%	-0.99%	-2.30%	-1.31%	-13.41%
Return on Equity (ROE)	21.32%	12.91%	8.54%	10.50%	12.86%	3.08%	9.41%	12.83%	12.70%	3.01%
Cash Return on Invested Capital (CROIC)	-66.27%	-12.84%	100.55%	-83.80%	13.41%	6.68%	7.82%	14.89%	8.30%	18.45%
Operating Return on Assets (OROA)	15.41%	9.62%	10.52%	9.61%	10.55%	2.90%	9.16%	11.70%	10.40%	1.85%
Return on Assets (ROA)	11.78%	7.36%	4.77%	5.90%	7.63%	2.00%	6.27%	8.38%	8.40%	2.07%
Return on Common Equity (ROCE)	9.48%	12.91%	8.53%	10.49%	12.86%	3.08%	9.41%	12.81%	12.67%	3.00%
Return on Equity Simple (ROE_SIMPLE)	19.75%	12.44%	7.78%	10.30%	12.22%	3.04%	9.02%	12.81%	12.13%	2.94%
Net Operating Profit after Tax (NOPAT)	123	77	60	86	112	24	92	135	129	154
NOPAT Margin	12.11%	8.77%	4.61%	5.84%	7.39%	2.04%	6.17%	6.87%	6.61%	8.33%
Net Nonoperating Expense Percent (NNEP)	-2.70%	-3.53%	0.97%	-0.62%	-1.03%	9.43%	1.46%	-1.35%	5.82%	-47.93%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	12.97%	11.21%	12.64%
Cost of Revenue to Revenue	65.82%	62.38%	69.14%	70.55%	69.19%	71.28%	70.68%	70.12%	69.67%	70.58%
SG&A Expenses to Revenue	20.42%	24.53%	18.69%	17.67%	18.56%	19.86%	18.01%	18.37%	19.90%	17.02%
R&D to Revenue	2.50%	2.88%	2.40%	2.26%	2.34%	2.59%	2.52%	1.97%	2.14%	2.59%
Operating Expenses to Revenue	18.74%	26.50%	21.30%	20.41%	20.90%	25.90%	20.41%	20.34%	22.04%	19.78%
Earnings before Interest and Taxes (EBIT)	156	106	136	139	155	42	136	186	172	32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	192	144	187	188	203	88	179	226	211	75
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.94	2.29	1.98	1.71	2.60	2.26	2.09	2.39	2.64	2.27
Price to Tangible Book Value (P/TBV)	6.97	11.14	3.63	4.35	5.41	4.29	3.53	3.91	4.38	3.60
Price to Revenue (P/Rev)	1.16	1.69	1.20	0.95	1.58	1.79	1.45	1.26	1.55	1.49
Price to Earnings (P/E)	9.84	18.40	25.42	16.55	21.31	74.39	23.17	18.66	21.76	77.11
Dividend Yield	1.25%	1.07%	1.18%	1.55%	1.05%	1.20%	1.33%	1.28%	1.16%	1.41%
Earnings Yield	10.16%	5.43%	3.93%	6.04%	4.69%	1.34%	4.32%	5.36%	4.60%	1.30%
Enterprise Value to Invested Capital (EV/IC)	1.88	2.02	5.02	1.64	2.63	2.37	2.26	2.62	2.99	2.65
Enterprise Value to Revenue (EV/Rev)	1.21	1.89	1.20	1.01	1.57	1.73	1.36	1.19	1.45	1.33
Enterprise Value to EBITDA (EV/EBITDA)	6.39	11.55	8.41	7.95	11.71	23.53	11.29	10.35	13.36	32.64
Enterprise Value to EBIT (EV/EBIT)	7.83	15.69	11.52	10.80	15.31	49.62	14.84	12.58	16.42	77.14
Enterprise Value to NOPAT (EV/NOPAT)	9.98	21.54	26.05	17.34	21.24	84.52	22.03	17.32	21.92	16.01
Enterprise Value to Operating Cash Flow (EV/OCF)	10.36	15.81	18.99	14.25	14.70	14.11	21.63	28.60	13.63	13.34
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	2.74	0.00	19.50	34.81	29.30	17.59	37.03	14.25
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.31	0.42	0.00	0.26	0.07	0.03	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.22	0.40	0.00	0.23	0.06	0.03	0.00	0.00	0.00	0.00
Financial Leverage	-0.21	0.17	-0.21	-0.24	0.04	-0.05	-0.11	-0.14	-0.16	-0.21
Leverage Ratio	1.81	1.76	1.79	1.78	1.69	1.54	1.50	1.53	1.51	1.46
Compound Leverage Factor	1.76	1.70	1.68	1.69	1.63	1.47	1.48	1.52	1.53	1.88
Debt to Total Capital	23.82%	29.48%	0.00%	20.35%	6.14%	2.97%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	6.96%	1.28%	0.00%	2.24%	0.10%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	16.86%	28.20%	0.00%	18.11%	6.04%	2.97%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.04%	0.03%	0.00%	0.05%	0.04%	0.05%	0.06%	0.23%	0.22%	0.40%
Common Equity to Total Capital	76.14%	70.49%	100.00%	79.60%	93.82%	96.98%	99.94%	99.77%	99.78%	99.60%
Debt to EBITDA	0.99	1.89	0.00	1.12	0.30	0.33	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.25	1.19	0.00	0.47	-0.08	-0.87	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.70	1.81	0.00	1.00	0.29	0.33	0.00	0.00	0.00	0.00
Debt to NOPAT	1.54	3.53	0.00	2.45	0.54	1.19	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.39	2.21	0.00	1.02	-0.14	-3.14	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	1.09	3.38	0.00	2.18	0.53	1.19	0.00	0.00	0.00	0.00
Altman Z-Score	4.12	3.67	20.63	3.55	4.97	4.81	4.67	5.41	5.93	5.53
Noncontrolling Interest Sharing Ratio	55.52%	0.05%	0.02%	0.03%	0.05%	0.05%	0.06%	0.14%	0.22%	0.31%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.23	2.41	0.00	2.24	2.08	2.24	2.16	2.15	2.38	2.58
Quick Ratio	1.35	1.40	0.00	1.36	1.21	1.29	1.27	1.19	1.52	1.70
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-294	-95	572	-514	122	59	69	133	76	173
Operating Cash Flow to CapEx	451.15%	639.39%	295.36%	348.51%	521.29%	491.25%	257.46%	194.06%	268.87%	298.54%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.00	0.80	1.01	1.02	1.03	0.83	1.00	1.24	1.18	1.07
Accounts Receivable Turnover	0.00	6.05	0.00	0.00	5.29	4.65	5.86	6.34	5.61	5.26
Inventory Turnover	0.00	3.30	0.00	0.00	4.25	3.66	4.21	4.23	4.03	4.33
Fixed Asset Turnover	0.00	7.57	0.00	0.00	7.66	5.83	6.98	9.02	7.97	6.86
Accounts Payable Turnover	0.00	9.86	0.00	0.00	8.42	7.71	8.48	8.77	8.26	7.96
Days Sales Outstanding (DSO)	0.00	60.28	0.00	0.00	68.95	78.53	62.24	57.54	65.03	69.37
Days Inventory Outstanding (DIO)	0.00	110.51	0.00	0.00	85.86	99.71	86.61	86.24	90.49	84.22
Days Payable Outstanding (DPO)	0.00	37.02	0.00	0.00	43.36	47.36	43.06	41.62	44.21	45.87
Cash Conversion Cycle (CCC)	0.00	133.77	0.00	0.00	111.44	130.87	105.79	102.16	111.31	107.72
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	653	825	313	913	903	869	891	893	946	927
Invested Capital Turnover	2.28	1.20	2.30	2.41	1.67	1.35	1.69	2.20	2.12	1.97
Increase / (Decrease) in Invested Capital	417	172	-512	600	-10	-35	23	2.10	53	-19
Enterprise Value (EV)	1,224	1,668	1,571	1,495	2,376	2,059	2,016	2,337	2,825	2,461
Market Capitalization	1,176	1,496	1,571	1,407	2,391	2,135	2,157	2,482	3,026	2,745
Book Value per Share	$25.12	$27.25	$32.91	$33.78	$37.50	$38.42	$41.89	$41.91	$46.13	$48.56
Tangible Book Value per Share	$7.01	$5.60	$17.92	$13.26	$18.04	$20.26	$24.77	$25.61	$27.77	$30.60
Total Capital	795	927	794	1,036	979	974	1,033	1,040	1,150	1,216
Total Debt	189	273	0.00	211	60	29	0.00	0.00	0.00	0.00
Total Long-Term Debt	134	261	0.00	188	59	29	0.00	0.00	0.00	0.00
Net Debt	48	171	0.00	88	-16	-76	-142	-147	-204	-289
Capital Expenditures (CapEx)	26	17	28	30	31	30	36	42	77	62
Debt-free, Cash-free Net Working Capital (DFCFNWC)	166	168	-5.20	267	252	209	250	320	311	296
Debt-free Net Working Capital (DFNWC)	308	270	-5.20	391	328	314	392	467	514	585
Net Working Capital (NWC)	253	258	-5.20	367	327	314	392	467	514	585
Net Nonoperating Expense (NNE)	3.14	-3.86	-1.50	1.23	-0.37	-4.34	-1.59	1.95	-10	118
Net Nonoperating Obligations (NNO)	48	171	-481	88	-16	-76	-142	-147	-204	-289
Total Depreciation and Amortization (D&A)	35	38	50	50	48	46	43	40	39	44
Debt-free, Cash-free Net Working Capital to Revenue	16.42%	19.02%	-0.40%	18.11%	16.66%	17.48%	16.83%	16.28%	15.93%	16.04%
Debt-free Net Working Capital to Revenue	30.42%	30.55%	-0.40%	26.44%	21.66%	26.30%	26.39%	23.77%	26.39%	31.71%
Net Working Capital to Revenue	24.95%	29.21%	-0.40%	24.87%	21.60%	26.30%	26.39%	23.77%	26.39%	31.71%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.96	$3.39	$2.56	$3.48	$4.58	$1.17	$3.78	$5.37	$5.60	$1.43
Adjusted Weighted Average Basic Shares Outstanding	24.11M	24.00M	24.15M	24.40M	24.48M	24.56M	24.65M	24.79M	24.85M	24.93M
Adjusted Diluted Earnings per Share	$4.86	$3.33	$2.52	$3.45	$4.54	$1.16	$3.75	$5.32	$5.56	$1.42
Adjusted Weighted Average Diluted Shares Outstanding	24.61M	24.44M	24.49M	24.60M	24.73M	24.78M	24.85M	24.98M	25.02M	25.12M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	24.01M	24.07M	24.35M	24.43M	24.51M	24.60M	24.77M	24.77M	24.87M	24.96M
Normalized Net Operating Profit after Tax (NOPAT)	91	70	88	91	112	54	90	135	129	156
Normalized NOPAT Margin	8.96%	7.93%	6.70%	6.15%	7.39%	4.53%	6.08%	6.87%	6.61%	8.48%
Pre Tax Income Margin	15.04%	11.67%	9.80%	8.91%	9.94%	3.33%	9.06%	9.40%	8.95%	2.23%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	12.47%	73.68%	30.10%	25.53%	22.28%	89.20%	30.93%	23.83%	25.23%	108.99%
Augmented Payout Ratio	25.27%	84.01%	31.88%	27.18%	24.42%	96.52%	31.79%	28.27%	26.02%	110.96%

This table displays calculated financial ratios and metrics derived from Innospec's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	36.40%	23.60%	7.87%	2.74%	-9.53%	-3.13%	-1.84%	-9.45%	-4.46%	-5.64%
EBITDA Growth	42.89%	21.16%	-8.63%	-11.70%	-4.55%	-0.74%	17.78%	12.61%	-6.01%	-274.26%
EBIT Growth	57.69%	36.56%	-8.02%	-13.58%	-5.08%	-3.10%	19.02%	12.74%	-9.85%	-339.73%
NOPAT Growth	66.21%	1.32%	-9.83%	-23.62%	-12.79%	41.24%	24.98%	7.60%	-1.68%	-22.52%
Net Income Growth	65.38%	6.69%	-9.04%	-10.53%	1.29%	48.24%	24.70%	7.96%	-14.80%	-286.24%
EPS Growth	64.89%	5.15%	-8.90%	-10.08%	1.29%	47.06%	24.06%	6.90%	-15.29%	-286.67%
Operating Cash Flow Growth	1,321.43%	13.95%	175.17%	833.33%	45.98%	-7.65%	269.72%	-91.45%	26.51%	-64.50%
Free Cash Flow Firm Growth	-138.72%	645.11%	109.26%	216.44%	319.60%	-163.94%	-38.25%	-97.63%	-89.44%	408.84%
Invested Capital Growth	9.68%	0.24%	-5.90%	-6.85%	-7.11%	5.89%	-1.82%	2.89%	2.49%	-2.01%
Revenue Q/Q Growth	9.71%	-0.45%	-0.22%	-5.73%	-3.39%	6.59%	1.11%	-13.03%	1.93%	5.28%
EBITDA Q/Q Growth	11.89%	-8.26%	-0.74%	-13.33%	20.94%	-4.59%	17.78%	-17.14%	0.95%	-276.88%
EBIT Q/Q Growth	15.22%	-8.13%	-1.11%	-17.45%	26.56%	-6.21%	21.46%	-21.80%	1.20%	-349.41%
NOPAT Q/Q Growth	12.15%	-33.69%	15.06%	-10.72%	28.05%	7.39%	1.82%	-23.14%	16.99%	-15.37%
Net Income Q/Q Growth	19.81%	-34.11%	30.20%	-12.95%	35.64%	-3.57%	9.52%	-24.64%	7.05%	-310.78%
EPS Q/Q Growth	20.16%	-34.19%	30.39%	-12.78%	35.34%	-4.46%	10.00%	-24.85%	7.26%	-310.53%
Operating Cash Flow Q/Q Growth	630.67%	96.98%	-72.19%	152.29%	5.64%	24.61%	11.33%	-94.17%	1,463.83%	-65.03%
Free Cash Flow Firm Q/Q Growth	41.54%	150.55%	266.89%	7.39%	10.26%	-114.72%	454.33%	-95.88%	391.40%	330.50%
Invested Capital Q/Q Growth	-0.58%	-9.90%	4.46%	-0.45%	-0.86%	2.71%	-3.15%	4.32%	-1.25%	-1.79%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	30.41%	29.68%	29.00%	31.31%	29.56%	31.47%	31.13%	29.17%	27.99%	29.18%
EBITDA Margin	11.56%	10.65%	10.60%	9.74%	12.20%	10.92%	12.71%	12.11%	12.00%	-20.16%
Operating Margin	9.77%	9.12%	8.05%	7.12%	9.03%	9.00%	10.10%	9.36%	10.28%	8.80%
EBIT Margin	9.59%	8.85%	8.77%	7.68%	10.06%	8.85%	10.64%	9.56%	9.49%	-22.49%
Profit (Net Income) Margin	7.54%	4.99%	6.51%	6.02%	8.45%	7.64%	8.28%	7.17%	7.53%	-15.08%
Tax Burden Percent	79.14%	56.42%	73.78%	78.96%	82.53%	83.44%	74.86%	71.40%	74.55%	68.62%
Interest Burden Percent	99.39%	100.00%	100.67%	99.19%	101.71%	103.42%	103.95%	105.05%	106.41%	97.71%
Effective Tax Rate	20.86%	43.58%	26.22%	21.04%	17.47%	16.56%	25.14%	28.60%	25.45%	0.00%
Return on Invested Capital (ROIC)	15.22%	11.33%	12.34%	11.75%	15.31%	15.91%	15.85%	13.43%	15.41%	12.15%
ROIC Less NNEP Spread (ROIC-NNEP)	16.22%	11.88%	9.72%	10.16%	12.31%	15.53%	14.13%	12.37%	15.64%	52.39%
Return on Net Nonoperating Assets (RNNOA)	-1.48%	-1.65%	-1.02%	-1.11%	-1.71%	-2.49%	-2.60%	-2.19%	-3.36%	-10.91%
Return on Equity (ROE)	13.74%	9.67%	11.33%	10.64%	13.60%	13.42%	13.25%	11.23%	12.04%	1.23%
Cash Return on Invested Capital (CROIC)	4.96%	14.89%	19.75%	19.92%	19.83%	8.30%	16.60%	11.86%	12.33%	18.45%
Operating Return on Assets (OROA)	11.32%	10.95%	10.81%	9.52%	12.03%	10.42%	12.29%	10.94%	10.41%	-24.12%
Return on Assets (ROA)	8.91%	6.18%	8.03%	7.46%	10.10%	8.99%	9.56%	8.21%	8.26%	-16.17%
Return on Common Equity (ROCE)	13.72%	9.66%	11.31%	10.62%	13.57%	13.39%	13.22%	11.20%	12.01%	1.23%
Return on Equity Simple (ROE_SIMPLE)	12.06%	0.00%	12.03%	11.56%	11.27%	0.00%	12.45%	12.54%	11.57%	0.00%
Net Operating Profit after Tax (NOPAT)	40	26	30	27	35	37	38	29	34	29
NOPAT Margin	7.73%	5.15%	5.94%	5.62%	7.45%	7.51%	7.56%	6.68%	7.67%	6.16%
Net Nonoperating Expense Percent (NNEP)	-1.00%	-0.55%	2.63%	1.60%	3.00%	0.38%	1.72%	1.05%	-0.23%	-40.24%
Return On Investment Capital (ROIC_SIMPLE)	-	2.53%	-	-	-	3.23%	-	-	-	2.37%
Cost of Revenue to Revenue	69.59%	70.32%	71.00%	68.69%	70.44%	68.53%	68.87%	70.83%	72.01%	70.82%
SG&A Expenses to Revenue	18.67%	18.92%	18.88%	21.98%	18.03%	20.68%	18.53%	16.87%	15.07%	17.37%
R&D to Revenue	1.97%	1.64%	2.08%	2.21%	2.50%	1.80%	2.36%	2.80%	2.50%	2.72%
Operating Expenses to Revenue	20.64%	20.56%	20.96%	24.19%	20.53%	22.48%	21.03%	19.82%	17.70%	20.37%
Earnings before Interest and Taxes (EBIT)	49	45	45	37	47	44	53	42	42	-105
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	59	54	54	47	57	54	64	53	53	-94
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.90	2.39	2.31	2.26	2.23	2.64	2.69	2.58	2.27	2.27
Price to Tangible Book Value (P/TBV)	2.98	3.91	3.72	3.60	3.49	4.38	4.38	4.15	3.58	3.60
Price to Revenue (P/Rev)	1.11	1.26	1.25	1.23	1.28	1.55	1.64	1.63	1.51	1.49
Price to Earnings (P/E)	15.76	18.66	19.23	19.53	19.79	21.76	21.64	20.60	19.61	77.11
Dividend Yield	1.46%	1.28%	1.27%	1.35%	1.33%	1.16%	1.10%	1.20%	1.31%	1.41%
Earnings Yield	6.35%	5.36%	5.20%	5.12%	5.05%	4.60%	4.62%	4.85%	5.10%	1.30%
Enterprise Value to Invested Capital (EV/IC)	1.99	2.62	2.52	2.48	2.50	2.99	3.19	2.98	2.67	2.65
Enterprise Value to Revenue (EV/Rev)	1.06	1.19	1.17	1.14	1.17	1.45	1.51	1.50	1.35	1.33
Enterprise Value to EBITDA (EV/EBITDA)	9.12	10.35	10.64	10.74	10.88	13.36	13.21	12.54	11.28	32.64
Enterprise Value to EBIT (EV/EBIT)	11.36	12.58	12.92	13.09	13.29	16.42	16.17	15.35	13.95	77.14
Enterprise Value to NOPAT (EV/NOPAT)	14.66	17.32	17.85	18.64	19.36	21.92	21.40	20.54	18.29	16.01
Enterprise Value to Operating Cash Flow (EV/OCF)	27.36	28.60	17.72	11.81	10.81	13.63	10.97	13.18	10.90	13.34
Enterprise Value to Free Cash Flow (EV/FCFF)	41.94	17.59	12.36	12.01	12.16	37.03	19.03	25.46	21.93	14.25
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.09	-0.14	-0.10	-0.11	-0.14	-0.16	-0.18	-0.18	-0.22	-0.21
Leverage Ratio	1.52	1.53	1.51	1.50	1.48	1.51	1.48	1.45	1.44	1.46
Compound Leverage Factor	1.51	1.53	1.52	1.49	1.51	1.56	1.54	1.52	1.53	1.42
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.23%	0.23%	0.22%	0.24%	0.24%	0.22%	0.22%	0.28%	0.34%	0.40%
Common Equity to Total Capital	99.77%	99.77%	99.78%	99.76%	99.76%	99.78%	99.78%	99.72%	99.66%	99.60%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	4.47	5.12	5.27	5.40	5.64	5.69	5.96	6.13	5.46	5.27
Noncontrolling Interest Sharing Ratio	0.15%	0.14%	0.14%	0.15%	0.23%	0.22%	0.22%	0.26%	0.29%	0.31%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.22	2.15	2.29	2.34	2.51	2.38	2.50	2.63	2.59	2.58
Quick Ratio	1.16	1.19	1.28	1.31	1.49	1.52	1.61	1.62	1.69	1.70
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-48	24	89	95	105	-15	55	2.26	11	48
Operating Cash Flow to CapEx	410.31%	519.21%	99.09%	317.92%	347.90%	343.13%	563.64%	30.92%	628.21%	124.76%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.18	1.24	1.23	1.24	1.20	1.18	1.16	1.14	1.10	1.07
Accounts Receivable Turnover	5.78	6.34	5.88	6.19	6.07	5.61	5.87	6.20	5.92	5.26
Inventory Turnover	4.02	4.23	4.17	3.92	3.86	4.03	4.00	3.93	4.03	4.33
Fixed Asset Turnover	8.90	9.02	8.95	8.91	8.71	7.97	7.72	7.37	7.17	6.86
Accounts Payable Turnover	8.49	8.77	8.28	8.31	8.62	8.26	7.79	8.63	8.32	7.96
Days Sales Outstanding (DSO)	63.11	57.54	62.03	58.98	60.16	65.03	62.16	58.89	61.65	69.37
Days Inventory Outstanding (DIO)	90.81	86.24	87.49	93.19	94.48	90.49	91.22	92.77	90.60	84.22
Days Payable Outstanding (DPO)	43.02	41.62	44.08	43.92	42.35	44.21	46.85	42.30	43.87	45.87
Cash Conversion Cycle (CCC)	110.90	102.16	105.45	108.25	112.30	111.31	106.54	109.36	108.38	107.72
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	991	893	933	929	921	946	916	956	944	927
Invested Capital Turnover	1.97	2.20	2.08	2.09	2.05	2.12	2.10	2.01	2.01	1.97
Increase / (Decrease) in Invested Capital	88	2.10	-59	-68	-71	53	-17	27	23	-19
Enterprise Value (EV)	1,973	2,337	2,348	2,304	2,305	2,825	2,920	2,845	2,521	2,461
Market Capitalization	2,071	2,482	2,494	2,467	2,510	3,026	3,187	3,081	2,821	2,745
Book Value per Share	$43.94	$41.91	$43.54	$43.92	$45.26	$46.13	$47.55	$47.83	$49.85	$48.56
Tangible Book Value per Share	$28.00	$25.61	$27.10	$27.54	$28.94	$27.77	$29.26	$29.80	$31.57	$30.60
Total Capital	1,092	1,040	1,081	1,095	1,128	1,150	1,186	1,196	1,248	1,216
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-101	-147	-148	-166	-207	-204	-270	-240	-304	-289
Capital Expenditures (CapEx)	9.70	15	22	17	17	21	14	15	12	21
Debt-free, Cash-free Net Working Capital (DFCFNWC)	365	320	346	324	312	311	278	304	289	296
Debt-free Net Working Capital (DFNWC)	465	467	493	490	520	514	548	544	593	585
Net Working Capital (NWC)	465	467	493	490	520	514	548	544	593	585
Net Nonoperating Expense (NNE)	0.95	0.79	-2.95	-1.90	-4.62	-0.67	-3.59	-2.14	0.60	99
Net Nonoperating Obligations (NNO)	-101	-147	-148	-166	-207	-204	-270	-240	-304	-289
Total Depreciation and Amortization (D&A)	10	9.20	9.30	9.90	9.90	10	10	11	11	11
Debt-free, Cash-free Net Working Capital to Revenue	19.53%	16.28%	17.29%	16.07%	15.89%	15.93%	14.33%	16.04%	15.41%	16.04%
Debt-free Net Working Capital to Revenue	24.92%	23.77%	24.66%	24.31%	26.44%	26.39%	28.26%	28.72%	31.63%	31.71%
Net Working Capital to Revenue	24.92%	23.77%	24.66%	24.31%	26.44%	26.39%	28.26%	28.72%	31.63%	31.71%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.56	$1.04	$1.34	$1.16	$1.58	$1.52	$1.66	$1.25	$1.34	($2.82)
Adjusted Weighted Average Basic Shares Outstanding	24.79M	24.79M	24.80M	24.87M	24.87M	24.85M	24.89M	24.94M	24.94M	24.93M
Adjusted Diluted Earnings per Share	$1.55	$1.02	$1.33	$1.16	$1.57	$1.50	$1.65	$1.24	$1.33	($2.80)
Adjusted Weighted Average Diluted Shares Outstanding	24.97M	24.98M	24.96M	24.98M	25.01M	25.02M	25.07M	25.10M	25.10M	25.12M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	24.76M	24.77M	24.87M	24.87M	24.87M	24.87M	24.93M	24.94M	24.94M	24.96M
Normalized Net Operating Profit after Tax (NOPAT)	40	26	30	27	35	37	38	29	34	30
Normalized NOPAT Margin	7.73%	5.15%	5.94%	5.62%	7.45%	7.51%	7.66%	6.78%	7.77%	6.36%
Pre Tax Income Margin	9.53%	8.85%	8.83%	7.62%	10.23%	9.16%	11.06%	10.05%	10.10%	-21.98%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	23.14%	23.83%	0.00%	26.37%	26.26%	25.23%	0.00%	24.67%	25.66%	108.99%
Augmented Payout Ratio	26.94%	28.27%	4.09%	29.69%	27.76%	26.02%	0.81%	25.20%	26.22%	110.96%

Frequently Asked Questions About Innospec's Financials

When does Innospec's financial year end?

According to the most recent income statement we have on file, Innospec's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Innospec's net income changed over the last 9 years?

In the past 9 years, Innospec's net income has ranged from $28.70 million in 2020 to $139.10 million in 2023, and is currently $35.60 million as of their latest financial filing in 2024.

What is Innospec's operating income?

Innospec's total operating income in 2024 was $177.90 million, based on the following breakdown:

Total Gross Profit: $542.90 million
Total Operating Expenses: $365 million

How has Innospec revenue changed over the last 9 years?

Over the last 9 years, Innospec's total revenue changed from $1.01 billion in 2015 to $1.85 billion in 2024, a change of 82.3%.

How much debt does Innospec have?

Innospec's total liabilities were at $518.60 million at the end of 2024, a 7.0% decrease from 2023, and a 22.5% increase since 2015.

How much cash does Innospec have?

In the past 9 years, Innospec's cash and equivalents has ranged from $0.00 in 2017 to $289.20 million in 2024, and is currently $289.20 million as of their latest financial filing in 2024.

How has Innospec's book value per share changed over the last 9 years?

Over the last 9 years, Innospec's book value per share changed from 25.12 in 2015 to 48.56 in 2024, a change of 93.3%.

Remove Ads

Related Companies

This page (NASDAQ:IOSP) was last updated on 4/14/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Innospec (IOSP) Financials

Frequently Asked Questions About Innospec's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Innospec (IOSP) Financials

Annual Income Statements for Innospec

Quarterly Income Statements for Innospec

Annual Cash Flow Statements for Innospec

Quarterly Cash Flow Statements for Innospec

Annual Balance Sheets for Innospec

Quarterly Balance Sheets for Innospec

Annual Metrics and Ratios for Innospec

Quarterly Metrics and Ratios for Innospec

Frequently Asked Questions About Innospec's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools